全文获取类型
收费全文 | 1723篇 |
免费 | 95篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 39篇 |
妇产科学 | 13篇 |
基础医学 | 237篇 |
口腔科学 | 39篇 |
临床医学 | 105篇 |
内科学 | 418篇 |
皮肤病学 | 4篇 |
神经病学 | 63篇 |
特种医学 | 137篇 |
外科学 | 342篇 |
综合类 | 8篇 |
预防医学 | 64篇 |
眼科学 | 28篇 |
药学 | 131篇 |
中国医学 | 4篇 |
肿瘤学 | 190篇 |
出版年
2023年 | 6篇 |
2022年 | 18篇 |
2021年 | 48篇 |
2020年 | 23篇 |
2019年 | 32篇 |
2018年 | 57篇 |
2017年 | 29篇 |
2016年 | 37篇 |
2015年 | 41篇 |
2014年 | 38篇 |
2013年 | 76篇 |
2012年 | 117篇 |
2011年 | 106篇 |
2010年 | 52篇 |
2009年 | 58篇 |
2008年 | 98篇 |
2007年 | 110篇 |
2006年 | 102篇 |
2005年 | 95篇 |
2004年 | 70篇 |
2003年 | 86篇 |
2002年 | 92篇 |
2001年 | 27篇 |
2000年 | 27篇 |
1999年 | 35篇 |
1998年 | 33篇 |
1997年 | 23篇 |
1996年 | 11篇 |
1995年 | 25篇 |
1994年 | 25篇 |
1993年 | 20篇 |
1992年 | 24篇 |
1991年 | 18篇 |
1990年 | 26篇 |
1989年 | 22篇 |
1988年 | 18篇 |
1987年 | 17篇 |
1986年 | 8篇 |
1985年 | 15篇 |
1984年 | 6篇 |
1983年 | 11篇 |
1982年 | 5篇 |
1981年 | 8篇 |
1980年 | 3篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1975年 | 2篇 |
1973年 | 2篇 |
1972年 | 2篇 |
1971年 | 2篇 |
排序方式: 共有1826条查询结果,搜索用时 406 毫秒
71.
Tomonori Suzuki Kuniko Kohyama Kengo Moriyama Mariko Ozaki Setsuko Hasegawa Taro Ueno Minoru Saitoe Tomohiro Morio Masaharu Hayashi Hiroshi Sakuma 《European journal of immunology》2020,50(2):205-219
The NLRP3 inflammasome is a molecular complex that translates signals from pathogens and tissue damage into inflammatory responses, and plays crucial roles in numerous neurological diseases. Activation of the NLRP3 inflammasome leads to caspase-1 dependent cleavage of pro-IL-1β to form mature IL-1β. By acting on the P2X7 purinergic receptor, extracellular ATP is one of the major stimuli that activates the NLRP3 inflammasome. Although microglia express multiple purinergic receptors, their roles in inflammasome-mediated inflammation are largely unknown. We studied the role of the P2Y12 receptor, a metabotropic P2Y receptor enriched in microglia, on inflammation in vitro. Inhibition of the microglial P2Y12 receptor by PSB0739 or siRNA knockdown suppressed IL-1β release. P2Y12 receptor-deficient microglia displayed markedly attenuated IL-1β mRNA expression and release. P2Y12 receptor blockade also suppressed IL-6 production. Both IL-1β and IL-6 responses were augmented by extracellular ADP or ADP-βS and were abrogated by PSB0739. Mechanistically, ADP-βS potentiated NF-κB activation. In addition, ADP altered mitochondrial membrane potential in combination with ATP and increased the number of caspase-1 positive cells through the P2Y12 receptor. These results elucidate a novel inflammatory mechanism by which extracellular ADP acts on the P2Y12 receptor to activate NF-κB and the NLRP3 inflammasome to enhance microglial inflammation. 相似文献
72.
73.
Satoshi Higuchi Ayako Okada Morio Shoda Daigo Yagishita Satoshi Saito Miwa Kanai Shohei Kataoka Kyoichiro Yazaki Hiroaki Tabata Hideki Kobayashi Wataru Shoin Takahiro Okano Koji Yoshie Koichiro Ejima Koichiro Kuwahara Nobuhisa Hagiwara 《老年心脏病学杂志》2021,18(7):505-513
BackgroundManagement of pacemaker (PM) infections among advanced aged patients possesses particular clinical challenges due to higher rates of concurrent cardiovascular disease and medical comorbidities. Novel leadless cardiac pacemakers (LCPs) may provide new opportunities for better management options in this population, however, there is limited data especially in Asian populations to guide the decision making.MethodsWe reviewed 11 octogenarians (median age: 86 [minimum 82–maximum 90] years; male: 73%; median body mass index (BMI): 20.1 kg/m2) who received Micra Transcatheter Pacing System (Medtronic Inc, Minneapolis, MN) implantations following transvenous lead extractions (TLEs) for PM infections. ResultsAll patients had more than two medical comorbidities (average 3.7 comorbidities). The indications for LCP implantations were atrioventricular block in four patients, atrial fibrillation bradycardia in five, and sinus node dysfunction in two. Eight patients (73%) were bridged with temporary pacing using active fixation leads (median interval of 14.0 days), while one with severe dementia underwent a concomitant LCP implantation and TLE during the same procedure. Successful TLEs and LCP implantations were successfully accomplished in all without any complications. The median time from the TLE procedure to discharge was 22 days (minimum 7–maximum 136). All patients remained free of infections during a mean follow-up period of 17.2 ± 6.5 months.ConclusionsLCP implantations were safe and effective after removing the entire infectious PM system in all octogenarians. The novel LCP technology may offer an alternative option for considering a re-implantation strategy after transvenous PM infections in elderly patients, particularly those with severe frailty and PM dependency.The incidence of cardiac pacemaker (PM) infections among patients with an advanced age has been increasing owing to the continually widening indications and growing number of generator replacements.[1–3] In current clinical practice, there is a class l indication for removing all hardware in the case of a proven or suspected device infection, and after a recovery window, a new conventional PM is implanted in PM dependent patients.[1,4,5] However, this management for the elderly population is one of the most sensitive issues, since they possess particular clinical challenges due to higher rates of concurrent cardiovascular disease and medical comorbidities.[6–10]Recently, the implantation of a Micra Transcatheter Pacing System (Medtronic Inc, Minneapolis, MN) has emerged as a new option for PM re-implantations after the removal of infectious PMs.[11–17] Without the use of leads and a device pocket, this leadless cardiac pacemaker (LCP) potentially reduces the risk of pocket infections and lead associated endocarditis.[16,17] However, there have not been enough data supporting the feasibility of leadless PM implantations following the removal of infectious PMs in people with an older age, particularly in octogenarians. Furthermore, there has been no data regarding those therapeutic strategies in Asian populations who have a low body mass index (BMI) and are at a higher risk of a transvenous lead extraction (TLE) procedure. Therefore, in this case series, we sought to characterize the procedure for LCP implantations following TLEs of infected PMs in octogenarians at 2 Japanese high-volume centers. 相似文献
74.
Yoshiteru Kagawa Banlanjo Abdulaziz Umaru Masayuki Kanamori Ryo Zama Subrata Kumar Shil Hirofumi Miyazaki Shuhei Kobayashi Tunyanat Wannakul Shuhan Yang Teiji Tominaga Yuji Owada 《Molecular oncology》2022,16(1):289
Isocitrate dehydrogenase 1 (IDH1) is a key enzyme in cellular metabolism. IDH1 mutation (IDH1mut) is the most important genetic alteration in lower grade glioma, whereas glioblastoma (GB), the most common malignant brain tumor, often has wild‐type IDH1 (IDH1wt). Although there is no effective treatment yet for neither IDH1wt nor IDHmut GB, it is important to note that the survival span of IDH1wt GB patients is significantly shorter than those with IDH1mut GB. Thus, understanding IDH1wt GB biology and developing effective molecular‐targeted therapies is of paramount importance. Fatty acid‐binding protein 7 (FABP7) is highly expressed in GB, and its expression level is negatively correlated with survival in malignant glioma patients; however, the underlying mechanisms of FABP7 involvement in tumor proliferation are still unknown. In this study, we demonstrate that FABP7 is highly expressed and localized in nuclei in IDH1wt glioma. Wild‐type FABP7 (FABP7wt) overexpression in IDH1wt U87 cells increased cell proliferation rate, caveolin‐1 expression, and caveolae/caveosome formation. In addition, FABP7wt overexpression increased the levels of H3K27ac on the caveolin‐1 promoter through controlling the nuclear acetyl‐CoA level via the interaction with ACLY. Consistent results were obtained using a xenograft model transplanted with U87 cells overexpressing FABP7. Interestingly, in U87 cells with mutant FABP7 overexpression, both in vitro and in vivo phenotypes shown by FABP7wt overexpression were disrupted. Furthermore, IDH1wt patient GB showed upregulated caveolin‐1 expression, increased levels of histone acetylation, and increased levels of acetyl‐CoA compared with IDH1mut patient GB. Taken together, these data suggest that nuclear FABP7 is involved in cell proliferation of GB through caveolae function/formation regulated via epigenetic regulation of caveolin‐1, and this mechanism is critically important for IDH1wt tumor biology. 相似文献
75.
76.
Poly[bis(p-phenylphenoxy)phosphazene] (PB(4-Ph)PP) has been investigated employing X-ray diffraction technique and electron microscopy. Its unit cell dimensions were determined to be a = 4,18 nm, b = 1,83 nm and c = 0,957 nm with space group Pca21. At 21 5–220°C , PB(4-Ph)PP transforms into an anisotropic liquid-like phase corresponding to a new molecular ordering array. The thicker films are composed of the linked globules approximately 100 nm in diameter. Upon drawing, the globules transform into a rod-like morphology 15–40 nm in width and exhibit a highly oriented X-ray diffraction pattern. These unusual morphological features have been compared with features found in poly[bis(phenoxy)phosphazene] and poly[bis(halophenoxy)phosphazene] polymers. X-ray diffraction and crystallization results support a smectic-like side chain morphology. 相似文献
77.
Takehito Shukuya Ryo Atsuta Yoshiteru Morio Koichi Sato Tsutomu Suzuki Kuniaki Seyama Kazuhisa Takahashi 《Nihon Kokyūki Gakkai zasshi》2007,45(9):715-719
We report a case of pulmonary arteriovenous fistula with multiple hepatic arterioportal shunts. A 23-year-old man was admitted for evaluation of a nodular shadow in the right lower lung field. Chest CT showed a homogeneous and well-defined nodular shadow in the right S7. 3-dimensional CT revealed an arteriovenous fistula composed of a feeding artery and a draining vein in the right S7. Abdominal enhanced CT revealed a diffusely heterogeneous pattern in the liver parenchyma and the portal vein staining diffusely at the late arterial phase. We diagnosed pulmonary arteriovenous fistula associated with multiple hepatic arterioportal shunts. Pulmonary arteriovenous fistula is often associated with hereditary hemorrhagic telangiectasia (HHT). This case did not meet the criteria for HHT at this time. However, we could not exclude the possibility of HHT because clinical manifestations of HHT become apparent after 40 years old among 10% of patients. The natural history and treatment of HHT are not clear. We concluded that we should be careful to detect possible manifestations as HHT when we diagnose and follow up patients with pulmonary arteriovenous fistula. 相似文献
78.
Shiga T Hosaka F Wakaumi M Matsuda N Tanizaki K Kajimoto K Shoda M Hagiwara N Kasanuki H 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》2003,17(4):325-333
Brain natriuretic peptide (BNP) is a powerful neurohormonal marker of left ventricular function and prognosis. Amiodarone either has no effect or improves the haemodynamics in patients with left ventricular dysfunction, but its effect on BNP is unknown. This study evaluated the effect of amiodarone on plasma BNP level in patients with heart failure and ventricular tachyarrhythmia.Plasma BNP level was studied in 46 patients with heart failure ventricular tachyarrhythmia, before (baseline) and at week 2 and months 1, 3 and 6 of amiodarone treatment. In addition, 21 patients with heart failure and ventricular tachyarrhythmia, who received an implantable cardioverter defibrillator, but not amiodarone, were studied on the same schedule. All patients had previously received potent vasodilator and beta-blocker therapy. Echocardiography and Holter monitoring were also performed.Amiodarone significantly decreased plasma BNP levels at week 2 to month 6 during therapy. Heart rates and frequencies of premature ventricular complexes were markedly reduced by amiodarone. Echocardiographic findings did not show a change in left ventricular end-diastolic dimensions, despite a slight increase in fraction shortening at month 6 during amiodarone therapy. The above parameters showed no change in patients without amiodarone. The effect of heart rate, premature ventricular complexes, fraction shortening, serum creatinine or thyroid stimulating hormone level was not significantly associated with decrease in BNP level during amiodarone therapy by a multivariate analysis. Among amiodarone-treated patients, mortality was higher in 24 with BNP levels 100 pg/ml at month 6 than in 22 with BNP levels <100 pg/ml during a mean follow-up period of 31 months.Amiodarone appears to have a decreasing effect on plasma BNP level, as well as an antiarrhythmic effect, in patients with heart failure and ventricular tachyarrhythmia. 相似文献
79.
Prognostic factors for chronic active Epstein-Barr virus infection 总被引:11,自引:0,他引:11
Kimura H Morishima T Kanegane H Ohga S Hoshino Y Maeda A Imai S Okano M Morio T Yokota S Tsuchiya S Yachie A Imashuku S Kawa K Wakiguchi H;Japanese Association for Research on Epstein-Barr Virus Related Diseases 《The Journal of infectious diseases》2003,187(4):527-533
Chronic active Epstein-Barr virus infection (CAEBV) is a high-mortality and high-morbidity disease. To clarify the prognostic factors, a national survey was performed in Japan, and data for 82 patients who met the criteria for CAEBV were analyzed. Of these 82 patients, 47 were alive and 35 had already died. Multivariate analysis revealed that thromobocytopenia and age at disease onset were correlated with mortality. The probability of 5-year survival was 0.45 for older patients (onset age, > or = 8 years), 0.94 for younger patients (P<.001), 0.38 for patients with thrombocytopenia (platelet count < 12 x 10(4) platelets/microL at diagnosis), and 0.76 for patients without thrombocytopenia (P=.01). Furthermore, patients with T cell infection by EBV had shorter survival times than patients with natural killer cell infection (probability of 5-year survival, 0.59 vs. 0.87; P<.009). Patients with CAEBV with late onset of disease, thrombocytopenia, and T cell infection had significantly poorer outcomes. 相似文献
80.
Christopher G. Mayne Faye E. Nashold Yoshiteru Sasaki Colleen E. Hayes 《European journal of immunology》2009,39(2):589-599
Systemic lupus erythematosus pathology reflects autoantibody‐mediated damage due to a failure of B‐lymphocyte tolerance. We previously reported that B‐lymphopenic A/WySnJ mice develop a lupus‐like syndrome and linked this syndrome to the B‐cell maturation defect‐1 (Bcmd‐1) mutant allele of the B‐cell‐activating factor belonging to the TNF family‐receptor (Baffr) gene. Here, we further evaluate the genetic basis for autoimmunity in A/WySnJ mice. We produced B6.Bcmd‐1 and AW.Baffr?/? congenic mice (N5), and compared them with B6.Baffr?/? and A/WySnJ mice with respect to B‐lymphocyte development. Bcmd‐1‐expressing mice had more B cells with greater maturity than Baffr?/? mice regardless of genetic background, indicating that Bcmd‐1 encodes a partially functional BAFF‐R. We also compared these mice for lupus phenotypes to determine whether Bcmd‐1 is necessary and sufficient for disease, or whether the Baffr?/?‐ allele can also cause autoimmunity. The Baffr?/? allele did not lead to autoimmunity on either genetic background. In contrast, the Bcmd‐1 allele was necessary and sufficient for development of low levels of IgM autoantibodies in B6.Bcmd‐1 mice. However, Bcmd‐1 plus unidentified A/WySnJ modifier genes were necessary for development of IgG autoantibodies and renal pathology. We propose that in A/WySnJ mice an excess of BAFF per B cell rescues self‐reactive B cells through a partially functional BAFF‐R in a B‐lymphopenic environment. 相似文献